News & Eventsof the Peripheral Nerve Society
COVID-19 Vaccine and Guillain-Barré Syndrome
Patients affected by inflammatory PNS disorders, most notably Guillain-Barre syndrome (GBS), and their physicians are making enquiries to the PNS membership about the merits of receiving a COVID vaccination. The following commentary on this complex issue has been recently published by a team of PNS members, led by Professor Michael Lunn, which summaries the current evidence surrounding vaccination and GBS: https://doi.org/10.1093/brain/awaa444. For additional information on COVID-19 vaccines and the GBS|CIDP community, please click here.